Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging - A Randomized Controlled Double Blind Study

NCT02877758 is registered in ClinicalTrials.gov with Tomorrowlabs GmbH as lead sponsor.

NCT NCT02877758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02877758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging - A Randomized Controlled Double Blind Study
Lead sponsor
Tomorrowlabs GmbH
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 30, 2016
Completion date
February 28, 2017
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aging